Get started
Author

Majed A. Alshamrani

Polypharmacy and Medication-Related Problems in Hemodialysis Patients: A Call for Deprescribing
2018 · Majed Alshamrani, Abdullah Almalki, et al. · Pharmacy · 57
PDF
Determinants of Employee Retention in Pharmaceutical Companies: Case of Saudi Arabia
2023 · Majed Alshamrani, Sager Alharthi, et al. · Journal of Business and Management Studies · 22
PDF
Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
2018 · Doaa Naeem, Majed A. Alshamrani, et al. · Pharmacy · 18
PDF
Practical strategies to manage cancer patients during the COVID-19 pandemic: Saudi Oncology Pharmacy Assembly Experts recommendations
2020 · Majed Alshamrani, Atika AlHarbi, et al. · Journal of Oncology Pharmacy Practice · 17
PDF
Cancer Management in Saudi Arabia: Recommendations by the Saudi Oncology HeAlth Economics ExpeRt GrouP (SHARP)
2020 · Nora Alkhudair, Majed Alshamrani, et al. · Saudi Pharmaceutical Journal · 16
PDF
Evaluation of handling, storage, and disposal practices of oral anticancer medications among cancer patients and their caregivers at home setting in the Princess Noorah Oncology Center
2020 · Ashwag A Algethami, Majed A Alshamrani, et al. · Journal of Oncology Pharmacy Practice · 11
Emerging Role of Biosimilars in Oncology-Hematology in Saudi Arabia: A Practical Perspective
2019 · Mansoor A. Khan, Mohammed A. Aseeri, et al. · Global Journal on Quality and Safety in Healthcare · 11
Granulocyte Colony Stimulating Factor (G-CSF) Induced Splenic Infarction in Breast Cancer Patient Treated with Dose-Dense Chemotherapy Regimen
2019 · Majed A. Alshamrani, Meteb Al-Foheidi, et al. · Case Reports in Oncological Medicine · 11
PDF
The Incidence of Hematological Toxicities in Colorectal Cancer Patients Treated With Fluoropyrimidine-Based Regimens at Princess Noorah Oncology Center
2023 · Mansoor Khan, Sara Alharbi, et al. · Cureus · 9
PDF
Cost-efficiency analysis of conversion to biosimilar filgrastim for supportive cancer care and resultant expanded access analysis to supportive care and early-stage HER2+ breast cancer treatment in Saudi Arabia: simulation study
2023 · Consuela Cheriece Yousef, Mansoor Ahmed Khan, et al. · Journal of Medical Economics · 7
PDF
Comparison of Biosimilar Filgrastim with Innovator Fligrastim for Peripheral Blood Stem Cells Mobilization, Collection of CD34+ Stem Cells, and Engraftment in Patients Undergoing Autologous and Allogeneic Stem Cell Transplantation: A Single-Center Experience
2023 · Maha M. Islami, Mansoor Ahmed Khan, et al. · Annals of Transplantation · 7
Practical challenges and considerations in adopting biosimilars in oncology clinical practice within a large healthcare system
2025 · Mansoor A. Khan, Laila Carolina Abu Esba, et al. · Expert Review of Clinical Pharmacology · 4
Posaconazole versus voriconazole as antifungal prophylaxis for invasive fungal diseases in patients with hematological malignancies
2024 · Reem Almutairy, Mansoor Ahmed Khan, et al. · Journal of Oncology Pharmacy Practice · 4
Opioid-induced respiratory depression and risk factors in a tertiary hospital: A retrospective study
2022 · Nabil A. Almouaalamy, Majed Alshamrani, et al. · Saudi Pharmaceutical Journal · 4
PDF
Safety and discontinuation rate of immune checkpoint inhibitors used in patients with solid and hematological malignancies. A population based retrospective analysis
2021 · Alaa Shahbar, Majed Alshamrani, et al. · Journal of Oncology Pharmacy Practice · 4
Comparative Assessment of Drug Lag for Approved Oncology Targeted Therapies Between Saudi Arabia, the United States, and the European Union
2024 · Mohammed Alnuhait, Abdullah Alshammari, et al. · Therapeutic Innovation & Regulatory Science · 3
Revitalizing oncology medications access in Saudi Arabia: Current challenges and recommendations by the Saudi Oncology Pharmacy Assembly
2024 · Nora Alkhudair, Jude Howaidi, et al. · Journal of Oncology Pharmacy Practice · 2
Assessment of Cardiotoxicity Incidence in Patients Receiving HER-2-Targeted Therapies for Breast Cancer in Saudi Arabia
2024 · Alaa Shahbar, Abdullah A Alhifany, et al. · Clinical Medicine Insights Oncology · 2
Implementing Oncology Pharmacy Boot Camp for Advanced Pharmacy Practice Experience Students at a Regional Conference in Saudi Arabia
2023 · Mohammed Alnuhait, Atika Alharbi, et al. · Cureus · 2
PDF
Pharmacy practitioners’ adherence to safe-handling practices of chemotherapeutic drugs: A cross-sectional study in Saudi Arabia
2022 · Azieb Ogbaghebriel, Majed Alshamrani, et al. · Journal of Oncology Pharmacy Practice · 2
Impact of coronavirus of 2019 on the delivery of pharmacy services to patients with cancer: An international survey of oncology pharmacy practitioners
2021 · Grace Chazan, Jennifer Jupp, et al. · Journal of Oncology Pharmacy Practice · 2
Effectiveness of a Single Fixed Dose of 3 mg Rasburicase for the Prevention and Management of Hyperuricemia in Tumor Lysis Syndrome in Adults With Cancer
2024 · Sabirin Bakhsh, Mansoor Ahmed Khan, et al. · Cureus · 1
PDF
National expert consensus recommendations on influenza vaccination in Saudi Arabia (2025)
2026 · Ashraf Al Amir, Abdullah Alshehri, et al. · Journal of Family and Community Medicine
Climate-sensitive infectious diseases in transition: a scoping review of key diseases and their epidemiology, data applications and mechanism of outbreak response in Saudi Arabia
2026 · Lolwah Almousa, Ghadeer Alzahrani, et al. · BMC Infectious Diseases
Ambulatory care hematology/oncology pharmacy services: A comprehensive review by the Saudi Oncology Pharmacy Assembly
2024 · Nada Alsuhebany, Nora Alkhudair, et al. · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
PDF
Works count: 35
Citation count: 216
H-index: 9
I10-index: 8
Year
Topic
Type